Haemonetics Corp (HAE)
75.44
-1.46
(-1.90%)
USD |
NYSE |
Dec 20, 16:00
75.37
-0.07
(-0.09%)
Pre-Market: 20:00
Haemonetics Market Cap: 3.789B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp | 131.10B |
| ResMed Inc | 34.83B |
| Globus Medical Inc | 11.25B |
| Baxter International Inc | 15.06B |
| Abbott Laboratories | 198.13B |
Market Cap Related Metrics
| PE Ratio | 31.30 |
| PS Ratio | 2.849 |
| Price to Book Value | 4.311 |
| Price to Free Cash Flow | 190.58 |
| Price | 75.44 |
| Earnings Yield | 3.19% |
| Operating PE Ratio | 23.45 |
| Normalized PE Ratio | 31.75 |